Taylor D A, du Bois R M
Royal Brompton Hospital, London, UK.
Int J Tuberc Lung Dis. 2001 Dec;5(12):1086-98.
Over the last 30 years the clinical and histopathological definitions of the diffuse lung diseases have evolved considerably. Initially pathological entities were defined in parallel with clinico-radiological diagnoses, but these have more recently become consolidated into a more meaningful combined classification. These refinements have impacted on the diffuse lung diseases in particular, and have defined individual diseases more precisely than in previous classifications in which a number of distinct entities had been grouped together and mistaken for idiopathic pulmonary fibrosis, resulting in much confusion. The American Thoracic and European Respiratory Societies' committees, charged with the task of defining the idiopathic interstitial pneumonias, have recently published a statement on idiopathic pulmonary fibrosis, and a statement on the other idiopathic interstitial pneumonias should follow this year. Of these diseases, idiopathic pulmonary fibrosis is the most lethal, and this review deals with the impact that the changes in the nomenclature will have on our understanding of this and the other diseases with which idiopathic pulmonary fibrosis was previously confused and explores the implications of our new understanding on clinical practice. It also attempts to highlight areas of previous dogma in the literature that now need to be re-considered in the context of these more recent statements.
在过去30年里,弥漫性肺疾病的临床和组织病理学定义有了很大的发展。最初,病理实体是与临床放射学诊断并行定义的,但最近这些已被整合为一种更有意义的综合分类。这些改进尤其对弥漫性肺疾病产生了影响,并且比以往的分类更精确地定义了个体疾病,在以往的分类中,一些不同的实体被归在一起并被误认为特发性肺纤维化,导致了很多混乱。负责定义特发性间质性肺炎的美国胸科学会和欧洲呼吸学会委员会最近发表了一份关于特发性肺纤维化的声明,关于其他特发性间质性肺炎的声明将于今年发布。在这些疾病中,特发性肺纤维化是最致命的,本综述探讨了命名法的变化将对我们对这种疾病以及以前与特发性肺纤维化混淆的其他疾病的理解产生的影响,并探讨了我们的新理解对临床实践的意义。它还试图突出文献中以前的教条领域,这些领域现在需要在这些最新声明的背景下重新考虑。